Covered recipient · General Payments record
FREDERICK RUTHARDT
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,796.69
- Reported across 143 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $449.33 | 25 |
| Travel and Lodging | $125.00 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $305.68 | 18 |
| Acerta Pharma LLC | $158.81 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $58.51 | 3 |
| Janssen Biotech, Inc. | $51.33 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.59 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991164 | CMS |
| ABBVIE INC. | $27.11 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991166 | CMS |
| ABBVIE INC. | $15.20 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991168 | CMS |
| ABBVIE INC. | $14.02 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991170 | CMS |
| ABBVIE INC. | $21.36 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991172 | CMS |
| ABBVIE INC. | $24.08 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991174 | CMS |
| ABBVIE INC. | $22.21 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991176 | CMS |
| ABBVIE INC. | $8.87 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991178 | CMS |
| ABBVIE INC. | $30.91 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991180 | CMS |
| ABBVIE INC. | $13.06 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991182 | CMS |
| ABBVIE INC. | $6.28 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991184 | CMS |
| ABBVIE INC. | $22.33 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991186 | CMS |
| ABBVIE INC. | $4.02 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991188 | CMS |
| ABBVIE INC. | $12.74 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991190 | CMS |
| ABBVIE INC. | $18.82 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991192 | CMS |
| ABBVIE INC. | $23.64 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991194 | CMS |
| ABBVIE INC. | $18.17 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991196 | CMS |
| ABBVIE INC. | $17.27 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105991198 | CMS |
| AstraZeneca Pharmaceuticals LP | $33.81 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104227809 | CMS |
| AstraZeneca Pharmaceuticals LP | $58.00 | 10/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1105431390 | CMS |
| AstraZeneca Pharmaceuticals LP | $67.00 | 10/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1105640566 | CMS |
| Janssen Biotech, Inc. | $17.88 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078602829 | CMS |
| Janssen Biotech, Inc. | $18.45 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078602710 | CMS |
| Janssen Biotech, Inc. | $15.00 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078602787 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.29 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137665920 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.21 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137665922 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.01 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137665924 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.